Sound Shore Management TEVA PHARMACEUTICAL IND LTD transactions over time
TEVA
TEVA PHARMACEUTICAL IND LTD historical holders
total: 1
Transactions details
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q3
Harry Burn has been an institutional investor in TEVA PHARMACEUTICAL IND LTD (TEVA) since 2026 Q3. According to 2026 Q3 report, Harry Burn holds 3,673,882 shares with a market value of roughly $145.49M representing 4.55% of their equity portfolio. The fund/company first acquired TEVA in 2026 Q3, initially purchasing about 3.67M shares.
Does Harry Burn still hold TEVA?
Yes, Harry Burn continues to hold TEVA PHARMACEUTICAL IND LTD (TEVA). According to their 2026 Q3 report, they maintain a position of 3,673,882 shares valued at approximately $145.49M, representing 4.55% of their equity portfolio.
When did Harry Burn first invest in TEVA?
Harry Burn first invested in TEVA PHARMACEUTICAL IND LTD (TEVA) in 2026 Q3 at the reported quarter-end price of $39.60 per share, acquiring 3,673,882 shares in their initial purchase.
What is Harry Burn's average cost basis for TEVA?
Based on historical transaction data, Harry Burn's estimated cost basis for TEVA PHARMACEUTICAL IND LTD (TEVA) is approximately $39.60 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $39.60
TEVA transactions history by Sound Shore Management
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
4.55%
|
3,673,882
|
$39.60
|
$145,485,727
|
new
|
+4.55%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.